These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 33783483)
1. Concurrent diabetes and heart failure: interplay and novel therapeutic approaches. Karwi QG; Ho KL; Pherwani S; Ketema EB; Sun Q; Lopaschuk GD Cardiovasc Res; 2022 Feb; 118(3):686-715. PubMed ID: 33783483 [TBL] [Abstract][Full Text] [Related]
2. Heart Failure in Type 2 Diabetes Mellitus. Kenny HC; Abel ED Circ Res; 2019 Jan; 124(1):121-141. PubMed ID: 30605420 [TBL] [Abstract][Full Text] [Related]
3. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell. Khan S; Ahmad SS; Kamal MA Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531 [TBL] [Abstract][Full Text] [Related]
4. Stage-Based Management of Type 2 Diabetes Mellitus with Heart Failure. Osuna PM; Brown SJ; Tabatabai LS; Hamilton DJ Methodist Debakey Cardiovasc J; 2018; 14(4):257-265. PubMed ID: 30788011 [TBL] [Abstract][Full Text] [Related]
5. The role of hyperglycaemia in the development of diabetic cardiomyopathy. El Hayek MS; Ernande L; Benitah JP; Gomez AM; Pereira L Arch Cardiovasc Dis; 2021 Nov; 114(11):748-760. PubMed ID: 34627704 [TBL] [Abstract][Full Text] [Related]
7. Cardiomyopathy in obesity, insulin resistance and diabetes. Nakamura M; Sadoshima J J Physiol; 2020 Jul; 598(14):2977-2993. PubMed ID: 30869158 [TBL] [Abstract][Full Text] [Related]
8. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy. Ritchie RH; Zerenturk EJ; Prakoso D; Calkin AC J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293 [TBL] [Abstract][Full Text] [Related]
9. Asymptomatic Diabetic Cardiomyopathy: an Underrecognized Entity in Type 2 Diabetes. Stanton AM; Vaduganathan M; Chang LS; Turchin A; Januzzi JL; Aroda VR Curr Diab Rep; 2021 Sep; 21(10):41. PubMed ID: 34580767 [TBL] [Abstract][Full Text] [Related]
10. Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs. Packer M Cardiovasc Diabetol; 2020 May; 19(1):62. PubMed ID: 32404204 [TBL] [Abstract][Full Text] [Related]
11. Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach. Dei Cas A; Spigoni V; Ridolfi V; Metra M Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):38-50. PubMed ID: 23369136 [TBL] [Abstract][Full Text] [Related]
12. Heart Failure and Diabetes: Perspective of a Dangerous Association. Favaloro LE; Ratto RD; Musso C Curr Hypertens Rev; 2021; 17(2):85-93. PubMed ID: 33823781 [TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting. Wilson AJ; Gill EK; Abudalo RA; Edgar KS; Watson CJ; Grieve DJ Heart; 2018 Feb; 104(4):293-299. PubMed ID: 28954833 [TBL] [Abstract][Full Text] [Related]
15. Diabetic cardiomyopathy: a brief summary on lipid toxicity. Ke J; Pan J; Lin H; Gu J ESC Heart Fail; 2023 Apr; 10(2):776-790. PubMed ID: 36369594 [TBL] [Abstract][Full Text] [Related]
16. Heart failure and its complications in patients with diabetes: Mounting evidence for a growing burden. Ferrini M; Johansson I; Aboyans V Eur J Prev Cardiol; 2019 Dec; 26(2_suppl):106-113. PubMed ID: 31766920 [TBL] [Abstract][Full Text] [Related]